New publication from Singh lab in Genome Biology
Ancient Viral DNA Controls Genes Linked to Pre‑Eclampsia
Genome Biology, March 9, 2026, Paris.
Genome Biology, March 9, 2026, Paris.
📅 Dates: May 27–29, 2026
📍 Location: Institut Necker Enfants Malades (INEM), Paris, France
At the 21st ECCO (European Crohn’s and Colitis Organisation) Congress in Stockholm, Eya Toumi and 14 other researchers were recognized for the quality of their research projects.
"I am currently a Tier 2 Canada Research Chair in Immune Cell Dynamics, and Associate Professor in the Department of Physiology, an associate member of the Department of Microbiology and Immunology, and a member of MRCCT at McGill University. I began my career as a computational biologist focused on the ecology and evolution of infectious diseases.
Aude Bernheim est microbiologiste. Elle dirige une équipe de recherche à l’Institut Pasteur qui explore comment les bactéries se défendent contre leurs virus et la conservation de ces systèmes dans le vivant. Elle développes des méthodologies computationnelles et expérimentales pour découvrir de nouveaux mécanismes immunitaires à travers le vivant. Elle est également engagée pour promouvoir une science plus inclusive .
Mercedes Ricote has a degree in Biology from the Complutense University of Madrid (UCM) and obtained her PhD in Biology from the UCM in 1994. After defending her doctoral thesis, she joined the laboratory of Dr. CK Glass at the University of California, San Diego (California, USA), where she played a key role in the seminal discovery that the nuclear receptor PPAR and its ligands inhibited macrophage activation.
“I am focused on cellular biology in the context of neurological disease. I did my PhD at Paris Brain Institute with Dr Frédéric Darios on the implication of lysosomal storage disorder in Hereditary Spastic Paraplegia. In 2023, I joined Institute Imagine to work with Dr. Alice Lepelley on the role of mitochondrial nucleic acid leakage in the development of Interferonopathies.
Seminar topic: Control of genic and extragenic transcription in inflammation and cancer.
Gioacchino Natoli obtained his Medical Degree with honors from the University of Rome La Sapienza in 1991, with a thesis on the role of the Hepatitis B Virus X protein in hepatocellular carcinoma. He completed a residency in Internal Medicine at La Sapienza and pursued research training in molecular biology and gene regulation, including postdoctoral work at the University of California, San Diego, in the laboratory of Prof. Michael Karin.
Seminar topic: Multi-Omic data for patient stratification and personalized medicine in immuno-inflammatory diseases